Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.25 USD
395.60 M USD
10.44 B USD
219.90 M
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A
Sector
Industry
CEO
Hong Li
Website
Headquarters
Guangzhou
Founded
1997
ISIN
CNE100000387
FIGI
BBG000G38417
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513630
JPMorgan S&P Hong Kong Stock Connect Low Volatility DividendWeight
1.27%
Market value
20.07 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of GZPHF is 2.14 USD — it has decreased by −8.55% in the past 24 hours. Watch Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. stocks are traded under the ticker GZPHF.
GZPHF stock has fallen by −8.55% compared to the previous week, the month change is a −8.55% fall, over the last year Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. has showed a −25.69% decrease.
We've gathered analysts' opinions on Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. future price: according to them, GZPHF price has a max estimate of 2.98 USD and a min estimate of 2.91 USD. Watch GZPHF chart and read a more detailed Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. stock forecast: see what analysts think of Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. and suggest that you do with its stocks.
GZPHF reached its all-time high on May 30, 2018 with the price of 4.76 USD, and its all-time low was 0.20 USD and was reached on Oct 7, 2004. View more price dynamics on GZPHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GZPHF stock is 23.36% volatile and has beta coefficient of 0.42. Track Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. stock price on the chart and check out the list of the most volatile stocks — is Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. there?
Today Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. has the market capitalization of 3.93 B, it has decreased by −0.65% over the last week.
Yes, you can track Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. financials in yearly and quarterly reports right on TradingView.
Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. is going to release the next earnings report on Mar 12, 2026. Keep track of upcoming events with our Earnings Calendar.
GZPHF earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.06 USD resulting in a 13.49% surprise. The estimated earnings for the next quarter are 0.06 USD per share. See more details about Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. earnings.
GZPHF net income for the last quarter is 111.43 M USD, while the quarter before that showed 95.48 M USD of net income which accounts for 16.70% change. Track more Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. financial stats to get the full picture.
Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. dividend yield was 4.83% in 2024, and payout ratio reached 46.45%. The year before the numbers were 3.78% and 29.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 9, 2025, the company has 28.14 K employees. See our rating of the largest employees — is Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. on this list?
Like other stocks, GZPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. stock shows the strong sell signal. See more of Guangzhou Baiyunshan Pharmaceuticals Holdings Company Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.